These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1852265)

  • 41. Discriminative stimulus properties of the serotonin agonist 1-(3-trifluoromethylphenyl)piperazine (TFMPP).
    Glennon RA; McKenney JD; Young R
    Life Sci; 1984 Oct; 35(14):1475-80. PubMed ID: 6482668
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reversal of fenfluramine and fluoxetine anorexia by 8-OH-DPAT is attenuated following raphe injection of 5,7-dihydroxytryptamine.
    Currie PJ; Coscina DV; Fletcher PJ
    Brain Res; 1998 Jul; 800(1):62-8. PubMed ID: 9685586
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors.
    Nash JF; Brodkin J
    J Pharmacol Exp Ther; 1991 Nov; 259(2):820-5. PubMed ID: 1682486
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic fluoxetine-induced desensitization of 5-HT1A and 5-HT1B autoreceptors: regional differences and effects of WAY-100635.
    Newman ME; Shalom G; Ran A; Gur E; Van de Kar LD
    Eur J Pharmacol; 2004 Feb; 486(1):25-30. PubMed ID: 14751404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The 5-HT1 receptor agonist RU-24969 decreases 5-hydroxytryptamine (5-HT) release and metabolism in the rat frontal cortex in vitro and in vivo.
    Brazell MP; Marsden CA; Nisbet AP; Routledge C
    Br J Pharmacol; 1985 Sep; 86(1):209-16. PubMed ID: 2413936
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of the ethanol-like discriminative stimulus effects of 5-HT receptor agonists as a function of ethanol training dose.
    Grant KA; Colombo G; Gatto GJ
    Psychopharmacology (Berl); 1997 Sep; 133(2):133-41. PubMed ID: 9342779
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of 5-HT(1A) autoreceptors enhances the inhibitory effect of galanin on hippocampal 5-HT release in vivo.
    Yoshitake T; Yoshitake S; Yamaguchi M; Ogren SO; Kehr J
    Neuropharmacology; 2003 Feb; 44(2):206-13. PubMed ID: 12623219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Opposing roles for 5-HT1B and 5-HT3 receptors in the control of 5-HT release in rat hippocampus in vivo.
    Martin KF; Hannon S; Phillips I; Heal DJ
    Br J Pharmacol; 1992 May; 106(1):139-42. PubMed ID: 1504723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study.
    Koch S; Perry KW; Nelson DL; Conway RG; Threlkeld PG; Bymaster FP
    Neuropsychopharmacology; 2002 Dec; 27(6):949-59. PubMed ID: 12464452
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of SB-236057-A, a selective 5-HT1B receptor inverse agonist, on in vivo extracellular 5-HT levels in the freely-moving guinea-pig.
    Roberts C; Hatcher P; Hagan JJ; Austin NE; Jeffrey P; Wyman P; Gaster LM; Routledge C; Middlemiss DN
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Aug; 362(2):177-83. PubMed ID: 10961381
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Flesinoxan dose-dependently reduces extracellular 5-hydroxytryptamine (5-HT) in rat median raphe and dorsal hippocampus through activation of 5-HT1A receptors.
    Bosker FJ; de Winter TY; Klompmakers AA; Westenberg HG
    J Neurochem; 1996 Jun; 66(6):2546-55. PubMed ID: 8632181
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serotonergic effects and extracellular brain levels of eletriptan, zolmitriptan and sumatriptan in rat brain.
    Johnson DE; Rollema H; Schmidt AW; McHarg AD
    Eur J Pharmacol; 2001 Aug; 425(3):203-10. PubMed ID: 11513839
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 1-(3-Trifluoromethylphenyl) piperazine (TFMPP) in the ventral tegmental area reduces the effect of desipramine in the forced swimming test in rats: possible role of serotonin receptors.
    Cervo L; Grignaschi G; Nowakowska E; Samanin R
    Eur J Pharmacol; 1989 Nov; 171(1):119-25. PubMed ID: 2533079
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quinpirole attenuates striatal c-fos induction by 5-HT, opioid and muscarinic receptor agonists.
    Cook DF; Wirtshafter D
    Eur J Pharmacol; 1998 May; 349(1):41-7. PubMed ID: 9669494
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro and in vivo effects of d-fenfluramine: no apparent relation between 5-hydroxytryptamine release and hypophagia.
    Raiteri M; Bonanno G; Vallebuona F
    J Pharmacol Exp Ther; 1995 May; 273(2):643-9. PubMed ID: 7752066
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological characteristics of 5-hydroxytryptamine autoreceptors in rat brain slices incorporating the dorsal raphe or the suprachiasmatic nucleus.
    O'Connor JJ; Kruk ZL
    Br J Pharmacol; 1992 Jul; 106(3):524-32. PubMed ID: 1504738
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serotonergic properties of cocaine: effects on a 5-HT2 receptor-mediated behavior and on extracellular concentrations of serotonin and dopamine.
    Essman WD; Singh A; Lucki I
    Pharmacol Biochem Behav; 1994 Sep; 49(1):107-13. PubMed ID: 7816859
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of an inhibitor of tryptophan 2,3-dioxygenase and a combined inhibitor of tryptophan 2,3-dioxygenase and 5-HT reuptake in the rat.
    Salter M; Hazelwood R; Pogson CI; Iyer R; Madge DJ; Jones HT; Cooper BR; Cox RF; Wang CM; Wiard RP
    Neuropharmacology; 1995 Feb; 34(2):217-27. PubMed ID: 7617147
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of chronic treatment with amitriptyline and MDL 72394 on the control of 5-HT release in vivo.
    Sleight AJ; Smith RJ; Marsden CA; Palfreyman MG
    Neuropharmacology; 1989 May; 28(5):477-80. PubMed ID: 2725855
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The antiemetic drug trimethobenzamide prevents hypophagia due to acetyl salicylate, but not to 5-HT1B or 5-HT1C agonists.
    Kennett GA; Curzon G
    Psychopharmacology (Berl); 1988; 96(1):101-3. PubMed ID: 3147468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.